drugset / Trial / NCT00903877

Study of T3 for the Treatment of Fibromyalgia

NCT00903877

Completed 51 enrolled Stanford University
NaSingle-groupOpen-labelTreatment

Summary

Determine if T3 - the active form of thyroid hormone - is beneficial in fibromyalgia. Determine the feasibility and promise of an appropriately powered future prospective randomized controlled study of using T3 (the active form of thyroid hormone) for the treatment of fibromyalgia. We specifically aim to assess the feasibility, cost, obstacles and promise of conducting a prospective controlled study in the future.

Timeline

Start
2009-05
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Liothyronine Small molecule 25 ug
Subject Liothyronine Small molecule 50 ug

Indications